enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2021 to Q4 2025

Type / Class
Equity / Common Stock, $0.00001 par value
Symbol
NVNO on Nasdaq
Shares outstanding
20,505,656
Price per share
$0.34
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
6,482,362
Total reported value
$2,078,925
% of total 13F portfolios
0%
Share change
+420,499
Value change
+$103,120
Number of holders
35
Price from insider filings
$0.34
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PERCEPTIVE ADVISORS LLC 10% $737,465 2,048,515 Perceptive Advisors LLC 31 Dec 2025
SATTERFIELD THOMAS A JR 9% $1,348,650 1,822,500 Thomas A. Satterfield, Jr. 14 Nov 2025
KINGDON CAPITAL MANAGEMENT, L.L.C. 7.1% $5,804,044 1,359,261 Kingdon Capital Management, L.L.C. 02 Sep 2025
Nantahala Capital Management, LLC 3.5% -51% $624,180 -$540,807 688,940 -46% Nantahala Capital Management, LLC 30 Sep 2025

As of 31 Dec 2025, 35 institutional investors reported holding 6,482,362 shares of enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO). This represents 32% of the company’s total 20,505,656 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) together control 31% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
PERCEPTIVE ADVISORS LLC 8.6% 1,759,035 0% 0.01% $564,298
KINGDON CAPITAL MANAGEMENT, L.L.C. 6.2% 1,265,845 -6.9% 0.06% $406,083
CM Management, LLC 6.1% 1,250,000 +108% 0.34% $401,000
VANGUARD GROUP INC 1.5% 299,246 -65% 0% $96,058
GEODE CAPITAL MANAGEMENT, LLC 0.98% 201,244 0% 0% $64,566
GSA CAPITAL PARTNERS LLP 0.97% 198,592 +1380% 0.01% $64,000
JPMORGAN CHASE & CO 0.89% 182,303 -0.01% 0% $58,483
JANE STREET GROUP, LLC 0.87% 178,855 +149% 0% $57,377
TWO SIGMA INVESTMENTS, LP 0.78% 159,619 0% $51,206
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.65% 132,325 -14% 0% $42,450
ACT CAPITAL MANAGEMENT, LLC 0.56% 115,000 0% 0.03% $36,892
SIMPLEX TRADING, LLC 0.45% 93,082 +577% 0% $29,879
Westside Investment Management, Inc. 0.45% 92,650 -56% 0% $29,726
XTX Topco Ltd 0.33% 67,187 +60% 0% $21,554
TWO SIGMA SECURITIES, LLC 0.31% 62,582 +343% 0% $20,076
BlackRock, Inc. 0.29% 60,474 +1% 0% $19,400
RENAISSANCE TECHNOLOGIES LLC 0.25% 51,300 +76% 0% $16,457
HRT FINANCIAL LP 0.24% 49,234 -11% 0% $15,000
CITADEL ADVISORS LLC 0.21% 42,726 -22% 0% $13,707
STATE STREET CORP 0.2% 40,800 0% 0% $13,089
NORTHERN TRUST CORP 0.19% 38,081 0% 0% $12,216
Fermata Advisors, LLC 0.16% 32,717 -13% 0% $10,496
UBS Group AG 0.16% 32,121 +213% 0% $10,311
AQR CAPITAL MANAGEMENT LLC 0.1% 20,905 -8.4% 0% $6,706
Creative Planning 0.1% 20,905 -45% 0% $6,706

Institutional Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 6,482,362 $2,078,925 +$103,120 $0.32 35
2025 Q3 5,965,202 $5,403,122 -$2,803,262 $0.91 36
2025 Q2 5,079,935 $20,269,051 +$6,075,451 $3.99 36
2025 Q1 3,640,381 $9,573,837 -$1,748,914 $2.63 30
2024 Q4 4,263,270 $12,878,793 -$3,370,239 $3.02 35
2024 Q3 5,209,889 $17,503,055 +$5,731,334 $3.36 35
2024 Q2 3,289,256 $17,267,988 -$1,696,568 $5.25 25
2024 Q1 3,643,857 $19,822,808 -$2,947,912 $5.44 31
2023 Q4 4,248,631 $21,838,067 +$10,299,470 $5.14 29
2023 Q3 1,931,716 $10,411,381 +$240,978 $5.39 23
2023 Q2 1,917,021 $5,904,248 +$322,837 $3.08 22
2023 Q1 1,812,147 $8,498,422 +$709,547 $4.68 18
2022 Q4 1,659,323 $8,461,848 -$813,295 $5.10 22
2022 Q3 2,185,470 $13,727,584 +$305,043 $6.28 20
2022 Q2 2,145,805 $8,111,390 +$183,530 $3.78 20
2022 Q1 2,038,463 $12,985,879 -$292,702 $6.37 20
2021 Q4 2,080,875 $13,711,600 +$13,093,583 $6.59 23
2021 Q3 12,207 $127,000 +$127,000 $10.40 1